Related Experiment Videos
[Progress on genetic susceptibility to ankylosing spondylitis]
Rui-Wen Chen1, Yong Wang, Shu-Han Sun
1Institute of Medical Biotechnology & Molecular Genetics, Department of Medical Genetics, College of Basic Medical Sciences, Second Military Medical University, Shanghai, China. rwchen@smmu.edu.cn
Yi Chuan Xue Bao = Acta Genetica Sinica
|October 29, 2005
Summary
Ankylosing spondylitis (AS) is a genetic inflammatory disease. While HLA-B27 is a major susceptibility gene, research shows other genes, both within and outside the HLA region, also contribute to AS development.
Area of Science:
- Rheumatology
- Immunogenetics
- Genetics
Context:
- Ankylosing spondylitis (AS) is a prevalent, highly heritable inflammatory rheumatic condition.
- The human leukocyte antigen B27 (HLA-B27) has long been recognized as a primary genetic factor in AS susceptibility.
- Recent genetic studies indicate a broader genetic landscape influencing AS beyond HLA-B27.
Purpose:
- To review and summarize the diverse genes implicated in ankylosing spondylitis.
- To highlight the current advancements in understanding the genetic basis of AS.
- To discuss the roles of both HLA-B27 and non-B27 genes in AS etiology.
Summary:
- AS is strongly linked to genetics, with HLA-B27 being a key susceptibility gene.
- Genome-wide studies reveal genetic contributions from regions outside the HLA complex.
- Evidence supports the involvement of non-B27 genes in the disease's development and progression.
Impact:
- This review consolidates current knowledge on AS genetics, providing a foundation for future research.
- Understanding the genetic architecture of AS can lead to improved diagnostic markers.
- Identifying novel genetic factors may pave the way for targeted therapeutic strategies in AS treatment.